Newer Therapeutic Targets in Head and Neck Cancers
Launched by BANARAS HINDU UNIVERSITY · May 16, 2022
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring new treatment options for patients with head and neck cancers, including oral cancer. Researchers are investigating specific gene changes that may play a role in how these cancers develop and grow. The goal is to understand how these changes can help doctors choose more effective treatments for patients with these types of cancers, especially those related to alcohol and tobacco use.
To participate in this trial, you must be between the ages of 65 and 74 and have a confirmed diagnosis of primary head and neck cancer. Unfortunately, if you are under 18, pregnant, or have multiple cancers, you wouldn't be eligible. If you join the trial, you'll be part of important research that aims to improve treatment for head and neck cancers. The trial is currently recruiting participants, and your involvement could help advance our understanding of these diseases.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Histologically proven cases of primary head and neck cancers.
- Exclusion Criteria:
- • Patients under 18 years of age
- • Pregnant and lactating women
- • Multiple cancers or patients with cancer of other sites.
About Banaras Hindu University
Banaras Hindu University (BHU) is a prestigious institution located in Varanasi, India, renowned for its commitment to excellence in education and research across various disciplines, including medicine and health sciences. As a clinical trial sponsor, BHU leverages its robust academic infrastructure and multidisciplinary expertise to advance innovative research aimed at improving healthcare outcomes. The university fosters collaboration between researchers, healthcare professionals, and community stakeholders to ensure the ethical conduct and scientific rigor of its clinical trials, ultimately contributing to the advancement of medical knowledge and the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Varanasi, Up, India
Patients applied
Trial Officials
Manoj Pandey, MS, PhD
Principal Investigator
Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials